|Bid||77.95 x 1000|
|Ask||80.00 x 900|
|Day's Range||77.56 - 79.28|
|52 Week Range||68.25 - 131.95|
|Beta (5Y Monthly)||0.73|
|PE Ratio (TTM)||117.12|
|Earnings Date||Nov 05, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||110.48|
NEW YORK, NY / ACCESSWIRE / October 23, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below.
New Orleans, Louisiana--(Newsfile Corp. - October 22, 2020) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 24, 2020 to file lead plaintiff applications in a securities class action lawsuit against BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), if they purchased the Company's securities between February 28, 2020 and August 18, 2020, inclusive (the "Class Period"). This ...
NEW YORK, NY / ACCESSWIRE / October 22, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.